Platform
Workflows
Antibody Discovery
Viral Neutralization
Cell Line Development
Cell Therapy Development
Synthetic Biology
Advanced Automation
The Beacon
®
Optofluidic System
The Lightning™ Optofluidic System
The Culture Station™ System
Technology
Company
TechAccess Subscriptions
News
Press Releases
Blog
Newsletter
Events
Investors
Careers
Customers
Careers
Resources
Support
Get In Touch
Latest
News
News
04.23.20
Company Focuses on Finding Coronavirus Antibodies in Push for New Therapeutics
News
04.23.20
Beyond Testing: The Importance of Antibodies in Tackling Covid-19
News
04.23.20
Ablexis, AlivaMab Discovery Services, and Berkeley Lights Collaborate to Identify a Diverse Panel of Anti-SARS-CoV-2 Human Antibodies
News
04.17.20
Engineering During a Pandemic
News
04.10.20
The Race to Find a Covid-19 Drug in the Blood of Survivors
News
03.25.20
Timeline Shows 3 Paths to COVID-19 Treatment and Prevention
News
03.13.20
How the Coronavirus Validated Berkeley Lights’ Technology and Its Supply Chain
News
02.06.20
GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours
News
12.01.19
2019 Top 10 Innovations
News
10.01.19
Ginkgo Bioworks Taps Cell-Engineering Startup to Advance Services
News
07.16.19
Screening Living Cells at High Speed
News
07.01.19
Achieving Unique Synergies in Antibody Expression
News
05.15.19
Indistinguishable from Magic? Meet Berkeley Lights
News
04.04.19
The Engineering of Living Organisms Could Soon Start Changing Everything
News
02.20.19
The 2019 World’s Most Innovative Companies
News
01.10.19
Catalent Invests $200M in Fast-Growing Biologics Manufacturing Business
News
01.08.19
New Technology Speeds Discovery of Novel, Rare Therapeutic Antibodies
News
01.07.19
New Berkeley Lights Workflow Speeds Up Drug Discovery
«
‹
2
3
4
›